Brought to you by 
PerkinElmer and Procognia develop protein array platform
02 Feb 2005
Executive Summary
PerkinElmer and Procognia Ltd. (proteomics technologies) have agreed to develop and exclusively co-promote a drug discovery tool designed to support the analysis of protein glycosylation (a natural process that adds sugar to particular sites on a protein).
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PerkinElmer and Procognia develop protein array platform
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice